Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab.

Source:http://linkedlifedata.com/resource/pubmed/id/20010090

Download in:

View as

General Info

PMID
20010090